Brainsway CFO files initial share and option holdings

Brainsway Ltd. chief financial officer Ido Marom filed an initial ownership report showing his equity stake in the company.

Rhea-AI Filing Summary

Brainsway Ltd. chief financial officer Ido Marom filed an initial ownership report showing his equity stake in the company. He directly holds 51,250 Ordinary Shares, a figure that includes unvested restricted stock units that will vest in scheduled quarterly installments through dates extending to March 2030.

Marom also holds stock options over 46,875 Ordinary Shares granted in August 2023 and 17,500 Ordinary Shares granted in March 2024, both vesting in equal quarterly installments through 2027 and 2028, with exercise prices of NIS 4.28 and NIS 11.17 per share, respectively. This filing records existing holdings rather than new market purchases or sales.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Marom Ido

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Stock Options (right to buy)	--	--	--
holding	Stock Options (right to buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock Options (right to buy) — 64,375 contracts (Direct); Ordinary Shares — 51,250 shares (Direct)

Footnotes (6)

1. F1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
2. F2. This figure includes unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 8,750 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029, and (c) RSUs to receive 32,500 ordinary shares with 8,125 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.
3. F3. Stock options were granted on August 8, 2023, with the remaining options to purchase 46,875 ordinary shares vesting in equal quarterly installments until May 18, 2027.
4. F4. The exercise price is NIS 4.28 per share.
5. F5. Stock options were granted on March 5, 2024, with the remaining options to purchase 17,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.
6. F6. The exercise price is NIS 11.17 per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Brainsway (BWAY) CFO Ido Marom report on this Form 3?

Ido Marom reports his initial ownership in Brainsway, including 51,250 Ordinary Shares and multiple equity awards. These positions reflect his existing stake and compensation structure rather than new open‑market transactions or recent share purchases or sales.

How many Brainsway (BWAY) Ordinary Shares does the CFO hold?

The CFO holds 51,250 Ordinary Shares in Brainsway. According to the disclosure, this figure includes unvested restricted stock units that convert into one Ordinary Share each as they vest according to specified quarterly schedules through 2030.

What stock options does the Brainsway (BWAY) CFO have outstanding?

The CFO holds stock options granted in August 2023 for 46,875 Ordinary Shares and in March 2024 for 17,500 Ordinary Shares. Both grants vest in equal quarterly installments into 2027 and 2028, with exercise prices of NIS 4.28 and NIS 11.17 per share.

Are the Brainsway (BWAY) CFO’s equity awards in the Form 3 already vested?

Many of the CFO’s awards are unvested and vest over time. The RSUs and stock options vest in equal quarterly installments on schedules running to 2027, 2028, 2029, and 2030, aligning his compensation with longer‑term company performance.

Does this Brainsway (BWAY) Form 3 show the CFO buying or selling shares?

The Form 3 does not show new share purchases or sales. It is an initial ownership filing that lists the CFO’s existing Ordinary Share holdings, unvested restricted stock units, and stock options, rather than recording current market transactions.

How are Brainsway (BWAY) American Depositary Shares related to Ordinary Shares here?

The filing notes that Brainsway’s Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share currently represents one Ordinary Share, linking U.S.‑traded ADS units directly to the underlying Israeli‑listed Ordinary Shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Marom Ido

(Last) (First) (Middle)

16 HARTUM STREET, RAD TOWER, 14TH FLOOR

HAR HAHOTZVIM

(Street)

JERUSALEM 9777516

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Brainsway Ltd. [ BWAY ]

3a. Foreign Trading Symbol
[BWAY]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)(2)	51,250	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(3)	08/08/2033	Ordinary Shares(1)	46,875	(4)	D
Stock Options (right to buy)	(5)	03/05/2034	Ordinary Shares(1)	17,500	(6)	D

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. This figure includes unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 8,750 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029, and (c) RSUs to receive 32,500 ordinary shares with 8,125 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.

3. Stock options were granted on August 8, 2023, with the remaining options to purchase 46,875 ordinary shares vesting in equal quarterly installments until May 18, 2027.

4. The exercise price is NIS 4.28 per share.

5. Stock options were granted on March 5, 2024, with the remaining options to purchase 17,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.

6. The exercise price is NIS 11.17 per share.

	/s/ Ido Marom	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)